Top Markets
#1 Gama Token Gama Token +13.54%
#2 Songbird Songbird +6.27%
#3 Pons Pons +3.65%
#4 DAPPOS DAPPOS +2.69%
#5 TENDIES TENDIES +2.65%
#6 Bitway Bitway +2.27%
#7 Biconomy Biconomy +2.10%
#8 Orbs Orbs +2.02%
#9 BORA BORA +1.96%
#10 Fake World Assets Fake World Assets +1.90%
Coin of the day
Gama Token Gama Token
Settings
Language
ENGLISH
Currency
USD
Theme
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Rank in Stocks #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Share Price
$19.81
Last synced: 2026-08-28
Market Cap
$891.32M
Change (1 day)
1.39%
Change (1 year)
5.16%
Country
US
Trade Beta Bionics, Inc. (BBNX)

Category

Healthcare
Operating Margin for Beta Bionics, Inc. (BBNX)
Operating Margin as of 2026 TTM: 0.00%
According to Beta Bionics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Beta Bionics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.